A randomised controlled trial investigating ventilation imaging to improve the quality of life for patients with lung cancer treated with radiation therapy VITaL

This trial is testing a new treatment planning method for patients with lung cancer who will be treated with radiation therapy. This new method is called Computed Tomography (CT) ventilation imaging. It aims to help protect the healthiest parts of patient's lungs from being injured by the radiation therapy. The investigators will determine whether healthy lung sparing can improve the quality of life in these patients.


For more information about VITaL visit: https://image-x.sydney.edu.au/the-vital-clinical-trial/

Primary Sponsor

The University of Sydney

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Accrual Target

165

Trial Chairperson

Prof Paul Keall, Image X Institute, NSW, Australia

Trial Contact

qa@trog.com.au

Clinical Trial Registration

Related Post

World Radiotherapy Awareness Day promotion at ESTRO26
10 June, 2026

Global cancer community prepares to unite for 2026 World Radiotherapy Awareness Day

LATEST NEWS: 10 June 2026 The global radiation therapy

4 June, 2026

Report showcases a year of impactful research, collaboration and consumer engagement

LATEST NEWS: 4 June 2025 TROG’s latest Annual Research